Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Feb;23(2):257-67.
doi: 10.1590/s0102-311x2007000200002.

[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines]

[Article in Portuguese]
Gabriela Costa Chaves  1 , Maria Auxiliadora Oliveira, Lia Hasenclever, Luiz Martins de Melo
Affiliations
Free article
Review

[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines]

[Article in Portuguese]
Gabriela Costa Chaves et al. Cad Saude Publica. 2007 Feb.
Free article

Abstract

This article discusses the evolution of the international intellectual property rights system in three phases and the implications for public health, especially for the implementation of policies for access to medicines. During the first phase, characterized by the Paris and Berne Convention, signatory countries defined which technological fields should be protected (or not). Under the second phase, with the enforcement of the WTO TRIPS Agreement, countries are obliged to grant patent protection for all technological fields, including for the pharmaceutical industry. Within their national legislations, countries also have the opportunity to implement access to TRIPS flexibilities for medicines. With the third phase, characterized by the negotiation and signing of bilateral and regional free trade agreements, countries will have to implement TRIPS-plus provisions which may have negative implications for the TRIPS flexibilities as well as for policies for access to medicines. The authors conclude that the currently proposed international intellectual property rights system favors patent-holder rights and that a balance is needed between patent holders' and health rights.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Technological Advancements in Monoclonal Antibodies.
    Santos-Neto JF, Oliveira FO, Hodel KVS, Fonseca LMS, Badaró R, Machado BAS. Santos-Neto JF, et al. ScientificWorldJournal. 2021 Feb 10;2021:6663708. doi: 10.1155/2021/6663708. eCollection 2021. ScientificWorldJournal. 2021. PMID: 33628140 Free PMC article. Review.

Substances

LinkOut - more resources